{"database":"dbGaP","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Pdf":["ftp://ftp.ncbi.nlm.nih.gov/dbgap/studies/phs000505/phs000505.v1.p1/release_notes/Release_Notes.phs000505.RNA_Seq_GliomaStemCells.v1.p1.MULTI.pdf","ftp://ftp.ncbi.nlm.nih.gov/dbgap/studies/phs000505/phs000505.v1.p1/manifest/manifest_phs000505.RNA_Seq_GliomaStemCells.v1.p1.c1.GRU.pdf","ftp://ftp.ncbi.nlm.nih.gov/dbgap/studies/phs000505/phs000505.v2.p1/release_notes/Release_Notes.phs000505.RNA_Seq_GliomaStemCells.v2.p1.MULTI.pdf","ftp://ftp.ncbi.nlm.nih.gov/dbgap/studies/phs000505/phs000505.v2.p1/manifest/Study_Report.phs000505.RNA_Seq_GliomaStemCells.v2.p1.MULTI.pdf","ftp://ftp.ncbi.nlm.nih.gov/dbgap/studies/phs000505/phs000505.v1.p1/manifest/Study_Report.phs000505.RNA_Seq_GliomaStemCells.v1.p1.MULTI.pdf","ftp://ftp.ncbi.nlm.nih.gov/dbgap/studies/phs000505/phs000505.v2.p1/manifest/manifest_phs000505.RNA_Seq_GliomaStemCells.v2.p1.c1.GRU-MDS.pdf"],"Xml":["ftp://ftp.ncbi.nlm.nih.gov/dbgap/studies/phs000505/phs000505.v2.p1/pheno_variable_summaries/phs000505.v2.pht002973.v2.Glioblastoma_Stem_Cell_Lines_Sample_Attributes.data_dict.xml","ftp://ftp.ncbi.nlm.nih.gov/dbgap/studies/phs000505/phs000505.v1.p1/pheno_variable_summaries/phs000505.v1.pht002973.v1.Glioblastoma_Stem_Cell_Lines_Sample_Attributes.data_dict.xml","ftp://ftp.ncbi.nlm.nih.gov/dbgap/studies/phs000505/phs000505.v1.p1/GapExchange_phs000505.v1.p1.xml","ftp://ftp.ncbi.nlm.nih.gov/dbgap/studies/phs000505/phs000505.v2.p1/pheno_variable_summaries/phs000505.v2.pht002808.v2.Glioblastoma_Stem_Cell_Lines_Sample.data_dict.xml","ftp://ftp.ncbi.nlm.nih.gov/dbgap/studies/phs000505/phs000505.v1.p1/pheno_variable_summaries/phs000505.v1.pht002973.v1.p1.Glioblastoma_Stem_Cell_Lines_Sample_Attributes.var_report.xml","ftp://ftp.ncbi.nlm.nih.gov/dbgap/studies/phs000505/phs000505.v2.p1/pheno_variable_summaries/phs000505.v2.pht002808.v2.p1.Glioblastoma_Stem_Cell_Lines_Sample.var_report.xml","ftp://ftp.ncbi.nlm.nih.gov/dbgap/studies/phs000505/phs000505.v2.p1/GapExchange_phs000505.v2.p1.xml","ftp://ftp.ncbi.nlm.nih.gov/dbgap/studies/phs000505/phs000505.v2.p1/pheno_variable_summaries/phs000505.v2.pht002973.v2.p1.Glioblastoma_Stem_Cell_Lines_Sample_Attributes.var_report.xml","ftp://ftp.ncbi.nlm.nih.gov/dbgap/studies/phs000505/phs000505.v1.p1/pheno_variable_summaries/phs000505.v1.pht002808.v1.p1.Glioblastoma_Stem_Cell_Lines_Sample.var_report.xml","ftp://ftp.ncbi.nlm.nih.gov/dbgap/studies/phs000505/phs000505.v1.p1/pheno_variable_summaries/phs000505.v1.pht002808.v1.Glioblastoma_Stem_Cell_Lines_Sample.data_dict.xml","ftp://ftp.ncbi.nlm.nih.gov/dbgap/studies/phs000505/phs000505.v1.p1/pheno_variable_summaries/phs000505.v1.pht002807.v1.Glioblastoma_Stem_Cell_Lines_Subject.data_dict.xml","ftp://ftp.ncbi.nlm.nih.gov/dbgap/studies/phs000505/phs000505.v2.p1/pheno_variable_summaries/phs000505.v2.pht002807.v2.Glioblastoma_Stem_Cell_Lines_Subject.data_dict.xml","ftp://ftp.ncbi.nlm.nih.gov/dbgap/studies/phs000505/phs000505.v1.p1/pheno_variable_summaries/phs000505.v1.pht002807.v1.p1.Glioblastoma_Stem_Cell_Lines_Subject.var_report.xml","ftp://ftp.ncbi.nlm.nih.gov/dbgap/studies/phs000505/phs000505.v2.p1/pheno_variable_summaries/phs000505.v2.pht002807.v2.p1.Glioblastoma_Stem_Cell_Lines_Subject.var_report.xml"],"Other":["ftp://ftp.ncbi.nlm.nih.gov/dbgap/studies/phs000505/phs000505.v2.p1/dbGaPEx2.1.5.xsd","ftp://ftp.ncbi.nlm.nih.gov/dbgap/studies/phs000505/phs000505.v1.p1/pheno_variable_summaries/datadict_v2.xsl","ftp://ftp.ncbi.nlm.nih.gov/dbgap/studies/phs000505/phs000505.v1.p1/pheno_variable_summaries/varreports_v3.xsl","ftp://ftp.ncbi.nlm.nih.gov/dbgap/studies/phs000505/phs000505.v2.p1/pheno_variable_summaries/datadict_v2.xsl","ftp://ftp.ncbi.nlm.nih.gov/dbgap/studies/phs000505/phs000505.v1.p1/dbGaPEx2.1.5.xsd","ftp://ftp.ncbi.nlm.nih.gov/dbgap/studies/phs000505/phs000505.v2.p1/pheno_variable_summaries/varreports_v3.xsl"]},"type":"primary"},"statusCode":"OK","statusCodeValue":200}],"scores":null,"additional":{"omics_type":["Genomic"],"study_type":["RNA Sequencing","Stem Cell Lines"],"name_synonyms":["grade IV adult astrocytic tumour, RNA, human being, RNA Sequence Determination, RNA Sequence Determinations, glioblastoma (disease), Sequence Determination, WHO grade IV glioma, RNA Sequence, Gene, giant cell glioblastoma (histologic variant), Giant Cell, Grade IV, grade IV astrocytoma, Astrocytomas, Determinations, adult glioblastoma multiforme, primary glioblastoma multiforme, Gene Fusions, glioblastoma, Analysis, glioblastoma multiforme (disease), Giant Cell Glioblastomas, Fusion, glioblastoma multiforme, Glioblastoma, grade IV adult astrocytic tumor, Analyses, Determination, spongioblastoma multiforme, gliosarcoma (histologic variant), Glioblastomas, GBM, grade IV astrocytic tumor, grade IV astrocytic neoplasm, Giant Cell Glioblastoma, Sequence Determinations, man, Sequencing, human, grade IV astrocytic tumour, Astrocytoma, animal stem cell, Glioblastoma Multiforme, Grade IV Astrocytomas, RNA Sequence Analyses, grade IV adult Astrocytic tumor, RNA Sequence Analysis, Fusions, stem cell., RNA Sequencing, Grade IV Astrocytoma, Sequence Analyses, GBM (glioblastoma)"],"study_inc_exc":["
Inclusion: 1) Positive diagnosis of glioblastoma 2) Growth of fresh tumors in vitro in stem cell culture conditions.
"],"full_dataset_link":["https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000505"],"study_history":[null],"attribution":["Principal Investigators - Antonio Iavarone, MD - Columbia University, New York, NY, USA","Principal Investigators - Raul Rabadan, PhD - Columbia University, New York, NY, USA"],"repository":["dbGaP"],"description_synonyms":["Glioma 1, Glioma NOS, glial cell tumor, Beliefs, GLM, glial tumors, glioblastoma (disease), Blood, neuroglial tumor, Mixed Glioma, stalk, Neuroglial Tumor, Yperite, tumour of the neuroglia, Tumor, Serum, grade IV astrocytoma, Malignant, ter, malignant neuroglial neoplasm, malignant neuroglial tumour, Background, [M]Glioma NOS (morphologic abnormality), primary tumour, tumor of the neuroglia, Cultural, Line, 1, Whole Transcriptome Shotgun Sequencing, [M]Gliomas (morphologic abnormality), glioblastoma, Carrying, Mustard gas, 1'-thiobis(2-chloroethane), primary stem, Mixed Gliomas, high grade glioma, Backgrounds, ethnicity, grade IV adult astrocytic tumor, glioma (morphologic abnormality), Glioma NOS (morphologic abnormality), neuroglial tumour, Iprit, anon-WO0118547.126, stubby, Neoplasm of the Neuroglia, grade IV astrocytic tumor, Cultural Relativisms, Glial Neoplasm, grade IV astrocytic neoplasm, growl, free, culm, paired, neuroglial neoplasm, Genotypes, bis(2-chloroethyl) sulphide, Lost, DmelCG4216, glial tumor, CG14648, Bsg75C, Clients, 1-chloro-2-[(2-chloroethyl)sulfanyl]ethane, mustard gas, tumour of neuroglia, primary neoplasia sample, Gliomas (morphologic abnormality), Customs, DmelCG14648, [M]Gliomas, glomerular capillary basement membrane, culture, glioma, Tumors of Neuroglia, neoplasm of the neuroglia, HHT1, Tumors, GBM (glioblastoma), Glioma (except Nasal glioma, malignant glial tumor, Growl, 1-chloro-2-[(2-chloroethyl)thio]ethane, malignant glial tumour, axis, malignant glioma, malignant, WHO grade IV glioma, malignant glial neoplasm, Cell Lines, RNA-seq, obsolete_glioma, giant cell glioblastoma (histologic variant), Malignant Glioma, Cultural Backgrounds, Blood Serum, bis(2-chloroethyl) sulfide, malignant neuroglial tumor, Client, Cell, neoplasm of neuroglia, nev, Belief, sulfur mustard., shortened, Cultural Background, bis(2-chloroethyl)sulfane, Cultures, Genogroup, Term, primary glioblastoma multiforme, Gliomas, Mixed, Glial Cell Tumor, [M]Glioma NOS, glioblastoma multiforme (disease), END, glomerular filtration membrane, Lines, Glial Tumor, glioblastoma multiforme, NOS (except Nasal glioma, Neuroglial Neoplasm, Neuroglial Neoplasms, primary neoplasia, spongioblastoma multiforme, gliosarcoma (histologic variant), Glial Cell, Malignant glioma, CG4216, GBM, Senfgas, INSDC_feature:gene, Tumor of Neuroglia, tumor of neuroglia, Neoplasm of Neuroglia, Phenotypes, Genogroups, glial cell tumour, no ICD-O subtype, primary axis, Patient, primary tumor, Tumor of the Neuroglia, glial tumour, Glial Cell Tumors, not neoplastic), Malignant Gliomas, Relativisms, primary tumour sample, Glioma, glial neoplasm, high-grade glioma, ORW1, malignant (morphologic abnormality), Relativism, short, Cultural Relativism, Neoplasms of Neuroglia, Serums"],"additional_accession":[]},"is_claimable":false,"name":"Gene Fusion Discovery through RNA Sequencing of Human Glioblastoma Stem Cell Lines","description":"We used massively parallel, paired-end sequencing of expressed transcripts (RNA-seq) to detect novel gene fusions in short-term cultures of glioma stem-like cells freshly isolated from nine patients carrying primary glioblastoma multiforme (GBM). The culture of primary GBM tumors under serum-free conditions selects cells that retain phenotypes and genotypes closely mirroring primary tumor profiles as compared to serum-cultured glioma cell lines that have largely lost their developmental identities.
","dates":{"last_modification":"2013-07-24","creation":"2013-07-19"},"accession":"phs000505","cross_references":{"MESH":["Glioblastoma"],"PMID":["16697959","17974913"]}}